A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

December 19, 2023

Study Completion Date

December 19, 2023

Conditions

Dry Eye Syndromes

Interventions

DRUG

IC265 Ophthalmic Solution 1%

1 drop will be instilled in each eye twice a day

DRUG

Placebo Ophthalmic Solution (Vehicle)

1 drop will be instilled in each eye twice a day

Trial Locations (1)

Iacta Selected Site, Andover